Halozyme Therapeutics Inc.
04/24/2026 | Press release | Distributed by Public on 04/24/2026 14:07
Amendments to Bylaws (Form 8-K)
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change of Fiscal Year.
On April 22, 2026, the Board of Directors (the "Board") of Halozyme Therapeutics, Inc. (the "Company") amended the Company's Bylaws to revise (i) Section 2.5 to provide that directors may be removed from office at any time, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of the directors and (ii) Section 1.12 to clarify that any action required to be taken at any annual or special meeting of stockholders of the corporation, or any action which may be taken at any annual or special meeting of such stockholders, may not be taken without a meeting, consistent with Article FIFTH of the Certificate of Incorporation.
The foregoing description of the amendment of the Company's Bylaws is qualified in its entirety by reference to the full text of the Company's Bylaws, as amended, attached hereto as Exhibit 3.1 and incorporated herein by reference.
Halozyme Therapeutics Inc. published this content on April 24, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 24, 2026 at 20:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]